Friday, 29 December 2017

Fremanezumab for Preventive Treatment of Migraine

Fremanezumab is a humanized monoclonal antibody targeting calcitonin gene–related peptide (CGRP). It is administered monthly via SQ injection.

In this NEJM study, fremanezumab was effective as a preventive treatment for chronic migraine: http://ift.tt/2k9DoB2

via CasesBlog - Medical and Health Blog More READ Lake forest health and fitness http://ift.tt/2zKEuFf

No comments:

Post a Comment